Travere Therapeutics, Inc. SEC filings TVTX
Travere Therapeutics, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Oct 8, 2015. Its latest annual report, Form ARS, was filed on Apr 6, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 2, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 2, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Apr 6, 2026 | — |
| DEF 14A | Proxy statement | Apr 6, 2026 | May 19, 2026 |
| DEFA14A | Additional proxy material | Apr 1, 2025 | — |
| DEF 14A | Proxy statement | Apr 1, 2025 | May 15, 2025 |
| DEFA14A | Additional proxy material | Mar 27, 2024 | — |
| DEF 14A | Proxy statement | Mar 27, 2024 | May 8, 2024 |
| DEF 14A | Proxy statement | Apr 13, 2023 | — |
| DEF 14A | Proxy statement | Apr 4, 2022 | May 11, 2022 |
| DEF 14A | Proxy statement | Apr 16, 2021 | May 14, 2021 |
| PRE 14A | Preliminary proxy statement | Apr 6, 2021 | Apr 6, 2021 |
| DEF 14A | Proxy statement | Apr 14, 2020 | May 15, 2020 |
| DEF 14A | Proxy statement | Apr 4, 2019 | May 8, 2019 |
| DEF 14A | Proxy statement | Apr 5, 2018 | May 9, 2018 |
| DEF 14A | Proxy statement | Apr 14, 2017 | May 17, 2017 |
| DEF 14A | Proxy statement | Apr 4, 2016 | May 18, 2016 |
Showing 15 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- TVTX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- CA
- Headquarters
- San Diego, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1438533
- Former names
- Retrophin, Inc. (until Nov 13, 2020); Desert Gateway, Inc. (until Feb 19, 2013)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.